Allon Therapeutics, Inc. is updating on the strategic alternatives it has been reviewing and has generated a number of different strategic alternatives and opportunities that are being actively evaluated. Allon is aggressively managing ongoing operating expenses and the process includes considering all reasonable options for exploiting Allon's assets as well as securing additional financing.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+42.37% | 54.04B | |
+43.57% | 41.96B | |
-1.08% | 41.92B | |
-7.59% | 28.35B | |
+12.23% | 26.35B | |
-22.56% | 19B | |
+7.79% | 13B | |
+29.02% | 12.28B | |
+25.17% | 12.19B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Updates On Strategic Review Process